newsfilter
← Latest News
GlobeNewswire·

Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates

Over 580,000 VOQUEZNA® prescriptions filled to date, reflecting 49% growth since last earnings reportNet revenues of $39.5 million reported for Q2Full-year 2025 revenue guidance of $165 million to $175